🇺🇸 FDA
Pipeline program

Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category

42-1703

Phase 3 small_molecule completed

Quick answer

Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category for Epilepsy is a Phase 3 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aquestive Therapeutics
Indication
Epilepsy
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials